metabolic-diseases

Documents about metabolic-diseases

• Study Consortium for Evaluation of RNPC Program in Obese and Overweight Patients (SCOOP-RNPC)#882525ClinicalTrials.gov
• Effects of Sweetener Consumption on Risk Factors for Heart Disease in Prediabetic Subjects#1031828ClinicalTrials.gov
• A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes#982495ClinicalTrials.gov
• Correlations between the cumulative metabolic score for visceral fat and its dynamic trajectories with the onset of cardiovascular disease in middle-aged and older adults: findings from two prospective cohorts.#9882PubMed
• The importance and challenge of comparing stroke care, utilization and outcomes in Medicare Advantage and Fee-for-Service Medicare: a narrative review and vision for the future#20083DOAJ
• Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group#130583Springer Nature OA
• Volanesorsen Early Access Program for Patients With Familial Chylomicronemia Syndrome (FCS)#966375ClinicalTrials.gov
• The Effect of Potassium Bicarbonate on Bone and Several Physiological Systems During Immobilisation#801157ClinicalTrials.gov
• Urinary Function and Multimorbidity Risks: A Longitudinal Study in Beijing Community-Dwelling Elderly#885336ClinicalTrials.gov
• Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI#801015ClinicalTrials.gov
• The Effects of a Low-Glycemic Index Diabetes Management Program on Weight, Body Mass Index, Triglycerides, Cholesterol and Hemoglobin A1C Values#957550Louisiana Tech Digital Commons
• Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in Adults With Obesity#891111ClinicalTrials.gov
• Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients#803673ClinicalTrials.gov